About this Research Topic
BPD is the consequence of multiple factors, from prenatal and/or postpartum factors, which interfere with the development of the lower respiratory tract and lead to severe respiratory system disease. The most frequent and critical insult during neonatal periods is oxidative stress caused by oxygen therapy to treat newborns with respiratory disorders. Despite early surfactant therapy, optimal ventilation strategies and increased use of non-invasive positive pressure ventilation, BPD remains a major cause of morbidity and mortality during the first year of life. Many BPD infants experience significant respiratory morbidity, including increased airway reactivity and the development of obstructive airway diseases throughout childhood. There has been growing awareness that the origins of chronic obstructive pulmonary disease may arise early in life. However, no effective therapy is currently available to prevent and to treat the perinatal insult- or hyperoxia-induced developmental lung injury.
This Research Topic will provide a platform for the dissemination of recent advances in the prevention and treatment of postnatal developmental lung injury. The Topic includes preclinical and clinical studies and up-to-date knowledge in the pathophysiology of lung development and lung injury, as well as in the prevention and treatment of postnatal developmental lung injury.
Keywords: neonates, hyperoxia, lung injury, bronchopulmonary dysplasia, treatment
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.